Thus, we found no differences in the functional capacity of the tumor-infiltrating macrophage populations, indicating that reduced functional status in these cells is unlikely to explain why Tregs are not effectively depleted by anti-CTLA-4 treatment in B7x-expressing tumors. Here, VTCN1 is linked to neoplasm.